Hydroxyurea use in Lebanese patients with beta-thalassemia intermedia

J Pediatr Hematol Oncol. 2006 Feb;28(2):107. doi: 10.1097/01.mph.0000200671.39549.2b.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Combined Modality Therapy
  • Genetic Variation
  • Humans
  • Hydroxyurea / therapeutic use*
  • Lebanon
  • Middle Aged
  • Splenectomy
  • Treatment Failure
  • beta-Thalassemia / drug therapy*
  • beta-Thalassemia / genetics
  • beta-Thalassemia / surgery

Substances

  • Hydroxyurea